NCT04351919View on ClinicalTrials.gov

Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 5, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Patients With COVID19
Interventions
DRUG

Hydroxychloroquine

400mg per day during 10 days

DRUG

Azithromycin

500 mg per day during 5 days

Trial Locations (1)

Unknown

Eshmoun Clinical Research Centre/ Hôpital Abderrahmen Mami-Ariana, Tunis

Sponsors
All Listed Sponsors
collaborator

Eshmoun Clinical Research Center

NETWORK

collaborator

Dacima Consulting

OTHER

lead

Abderrahmane Mami Hospital

OTHER